Coronary Revascularization
8
0
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Transfusion Trigger After Operations in High Cardiac Risk Patients
Women's Health Initiative Strong and Healthy Study
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Correlation Hand Grip Strength and Walking Distance in Elderly
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)
Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization
Real-time Feedback of SYNTAX Score Category During Coronary Angiographies to Improve Appropriateness of Coronary Revascularization for Patients With Stable Coronary Artery Diseases: a Before-and-after Controlled Study
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes